In the near future the FDA will release its “final” guidelines on mobile medical apps (MMAs). There has been much debate on the impact of these guidelines as well as what questions will remain unanswered post publication.

In the podcast Beyond Mobile Medical App Guidance  Pharma Marketing Talk and Bradley Merrill Thompson, General Counsel to the mHealth Regulatory Coalition, discuss the FDA’s final guidance on MMAs and other regulatory issues that the mobile health community and the FDA will need to face after publication of the “final” guidelines.